ß3-adrenergic receptor sustains IFN-γ-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma

被引：0
|
作者：
Bruno, Gennaro [1 ]
Nastasi, Nicoletta [1 ]
Subbiani, Angela [1 ]
Boaretto, Alessia [1 ]
Tondo, Annalisa [1 ]
Favre, Claudio [1 ]
Calvani, Maura [1 ]
机构：
[1] Meyer Childrens Hosp Florence, Florence, Italy
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3887
引用
收藏
页数：2
相关论文
共 50 条
  • [1] β3-adrenergic receptor on tumor-infiltrating lymphocytes sustains IFN-γ-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma
    Gennaro Bruno
    Nicoletta Nastasi
    Angela Subbiani
    Alessia Boaretto
    Sara Ciullini Mannurita
    Gianluca Mattei
    Patrizia Nardini
    Chiara Della Bella
    Alberto Magi
    Alessandro Pini
    Emanuela De Marco
    Annalisa Tondo
    Claudio Favre
    Maura Calvani
    Cancer Gene Therapy, 2023, 30 : 890 - 904
  • [2] β3-adrenergic receptor on tumor-infiltrating lymphocytes sustains IFN-γ-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma
    Bruno, Gennaro
    Nastasi, Nicoletta
    Subbiani, Angela
    Boaretto, Alessia
    Mannurita, Sara Ciullini
    Mattei, Gianluca
    Nardini, Patrizia
    Della Bella, Chiara
    Magi, Alberto
    Pini, Alessandro
    De Marco, Emanuela
    Tondo, Annalisa
    Favre, Claudio
    Calvani, Maura
    CANCER GENE THERAPY, 2023, 30 (06) : 890 - 904
  • [3] DNMT1 constrains IFNβ-mediated anti-tumor immunity and PD-L1 expression to reduce the efficacy of radiotherapy and immunotherapy
    Huang, Kevin Chih-Yang
    Chiang, Shu-Fen
    Ke, Tao-Wei
    Chen, Tsung-Wei
    Hu, Ching-Han
    Yang, Pei-Chen
    Chang, Hsin-Yu
    Liang, Ji-An
    Chen, William Tzu-Liang
    Chao, K. S. Clifford
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [4] S-allylmercaptocysteine promotes anti-tumor immunity by suppressing PD-L1 expression
    Zhao, Zhongxi
    Wei, Guangwei
    Zhao, Jianxiong
    Sun, Yueyue
    Gao, Peng
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 161
  • [5] Honokiol suppress the PD-L1 expression to improve anti-tumor immunity in lung cancer
    Luo, Lianxiang
    Wu, Tong
    Ji, Miaorong
    Xiang, Jing
    Zou, Youwen
    Liao, Yinglin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 133
  • [6] BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
    Zhu, Hengrui
    Bengsch, Fee
    Svoronos, Nikolaos
    Rutkowski, Melanie R.
    Bitler, Benjamin G.
    Allegrezza, Michael J.
    Yokoyama, Yuhki
    Kossenkov, Andrew V.
    Bradner, James E.
    Conejo-Garcia, Jose R.
    Zhang, Rugang
    CELL REPORTS, 2016, 16 (11): : 2829 - 2837
  • [7] KEAP1 promotes anti-tumor immunity by inhibiting PD-L1 expression in NSCLC
    Li, Jinghan
    Shi, Daiwang
    Li, Siyi
    Shi, Xiang
    Liu, Yu
    Zhang, Yi
    Wang, Gebang
    Zhang, Chenlei
    Xia, Tian
    Piao, Hai-long
    Liu, Hong-Xu
    CELL DEATH & DISEASE, 2024, 15 (02)
  • [8] Regorafenib attenuates IFN-γ-induced PD-L1 expression and enhances antitumor immunity
    Zhu, Xiao-Feng
    CANCER RESEARCH, 2018, 78 (13)
  • [9] MLL3 enhances the transcription of PD-L1 and regulates anti-tumor immunity
    Xiong, Wei
    Deng, Huanghao
    Huang, Changkun
    Zen, Chong
    Jian, Chengzhu
    Ye, Kun
    Zhong, Zhaohui
    Zhao, Xiaokun
    Zhu, Liang
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (02): : 454 - 463
  • [10] Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
    Poggio, Mauro
    Hu, Tianyi
    Pai, Chien-Chun
    Chu, Brandon
    Belair, Cassandra D.
    Chang, Anthony
    Montabana, Elizabeth
    Lang, Ursula E.
    Fu, Qi
    Fong, Lawrence
    Blelloch, Robert
    CELL, 2019, 177 (02) : 414 - +
12345